Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2010
12/02/2010US20100304401 Ys68 gene involved in primitive hematopoiesis
12/02/2010US20100304387 Methods and compositions for signal enhancement using multivalent interactions
12/02/2010US20100304369 Method and apparatus for diagnosing age-related macular degeneration
12/02/2010US20100303897 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production
12/02/2010US20100303858 Chimeric HIV-1 Glycoproteins and Their Biological Applications
12/02/2010US20100303849 Lipidated Vaccine against Dengue Virus Infection
12/02/2010US20100303844 Modification of intrinsically disordered sequences for the preparation of vaccines
12/02/2010US20100303843 RECOMBINANT ALLERGEN WITH REDUCED lgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
12/02/2010US20100303834 Compositions and methods for the diagnosis and treatment of tumor
12/02/2010US20100303833 Method for Identifying a MHC Class H-Dependent Tumor Associated T Helper Cell Antigen
12/02/2010US20100303831 Methods For The Treatment Of An Infectious Bacterial Disease With An Anti-Lactone Or Lactone Derived Signal Molecules Antibody
12/02/2010US20100303829 Hiv vpr-specific t cell receptors
12/02/2010US20100303828 Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells Activity
12/02/2010US20100303826 Use of ADCC-Optimized antibodies for treating weak patients
12/02/2010US20100303825 Anti-estrogen and immune modulator combinations for treating breast cancer
12/02/2010US20100303823 Human monoclonal antibodies against interleukin 8 (il-8)
12/02/2010US20100303822 Polypeptides from non-typeable haemophilus influenzae
12/02/2010US20100303821 Immunoglobulins
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303818 Dendritic cell receptor
12/02/2010US20100303817 Antibodies to treat cancer
12/02/2010US20100303816 Antibodies against human melanoma-associated chondroitin sulphate proteoglycan (mcsp)
12/02/2010US20100303814 Antibodies Against a Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
12/02/2010US20100303812 Neutralizing monoclonal antibody against human dll4
12/02/2010US20100303811 Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity.
12/02/2010US20100303810 Method for treating lupus
12/02/2010US20100303808 Humanized anti-cd20 antibodies and methods of use
12/02/2010US20100303807 Methods for the treatment of il-1beta related diseases
12/02/2010US20100303806 Avian derivedantibodies
12/02/2010US20100303805 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
12/02/2010US20100303802 Antibody directed to g protein coupled receptors (gpcr)
12/02/2010US20100303801 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
12/02/2010US20100303795 Marker of prostate cancer
12/02/2010US20100303771 Gaba neuron progenitor cell marker 65b13
12/02/2010US20100303736 Anti-il-9 antibody formulations and uses thereof
12/02/2010US20100303726 Humanized collagen antibodies and related methods
12/02/2010US20100303723 Drug delivery systems using fc fragments
12/02/2010US20100303720 VARIANTS OF HUMANIZED ANTI-CARCINOMA MAb CC49
12/02/2010US20100303715 Prostate-specific membrane antigen and uses thereof
12/02/2010CA2800182A1 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
12/02/2010CA2799608A1 Amino acid sequences which enhance peptide conjugate solubility
12/02/2010CA2763493A1 Antigen-binding proteins
12/02/2010CA2763491A1 Antigen-binding proteins
12/02/2010CA2763488A1 Antigen-binding proteins
12/02/2010CA2763469A1 Antigen-binding proteins
12/02/2010CA2763446A1 Stem cell targeting
12/02/2010CA2763443A1 Il-13 binding protein
12/02/2010CA2763439A1 Antigen-binding proteins
12/02/2010CA2763161A1 Cardiovascular related uses of il-1.beta. antibodies and binding fragments thereof
12/02/2010CA2763138A1 A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
12/02/2010CA2763115A1 Stim2-mediated capacitive calcium entry
12/02/2010CA2762934A1 Cdc45l peptides and vaccines including the same
12/02/2010CA2761233A1 Tri- or tetraspecific antibodies
12/02/2010CA2760757A1 Compositions and methods for antibodies targeting complement protein c3b
12/02/2010CA2758356A1 A collection and methods for its use
12/01/2010EP2256205A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256204A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256203A1 IL-23 and its receptor; related reagents and methods
12/01/2010EP2256202A2 Stimulus-inducible i (kappa)b kinase ikk signalsome
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256134A1 IgG Fc fragment for a drug carrier and method for the preparation thereof
12/01/2010EP2256132A1 Method of detecting proBNP with a monoclonal antibody binding to the amino acids 38-44
12/01/2010EP2255828A1 Methods of therapy for cancers expressing the CD40 antigen
12/01/2010EP2255194A1 Methods for prognosing the status of tumor patients
12/01/2010EP2254911A1 HUMANIZED ANTI-C5aR ANTIBODIES
12/01/2010EP2254910A1 Use of substances for sensitization of tumor cells to radiation and/or chemotherapy
12/01/2010EP2254909A1 NON-AGGREGATING HUMAN Vh DOMAINS
12/01/2010EP1842065B1 Methods for diagnosis and prognosis of bladder cancer
12/01/2010EP1644740B1 Assessment of skeletal growth using measurements of nt-cnp peptides
12/01/2010EP1644415B1 Antibodies against interleukin-22 and uses therefor
12/01/2010EP1589106B1 Adiponectin receptor and gene coding for the same
12/01/2010EP1572077B1 Uses of monoclonal antibody 8h9
12/01/2010EP1536004B1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody
12/01/2010EP1449850B1 Human cdr-grafted antibodies and antibody fragments thereof
12/01/2010EP1434800B1 Immunoglobulin having particular framework scaffold and methods of making and using
12/01/2010EP1423425B1 Receptor, the use thereof, and mouse antibodies
12/01/2010EP1414861B1 Humanized antibodies against icam-1, their production and uses
12/01/2010EP1373301B1 Reducing the immunogenicity of fusion proteins
12/01/2010EP1319089B1 In vitro assay for measuring the immunogenicity of a vaccine
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1824675B Neisserial antigens
12/01/2010CN1723042B Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
12/01/2010CN101903406A Bivalent, bispecific antibodies
12/01/2010CN101903405A Bivalent, bispecific antibodies
12/01/2010CN101903404A Bivalent, bispecific antibodies
12/01/2010CN101903403A CD19 binding agents and uses thereof
12/01/2010CN101903402A Humanized antibodies against TL1A
12/01/2010CN101903401A Stability testing of antibodies
12/01/2010CN101903399A Clostridial toxin netb
12/01/2010CN101903044A Antibodies specific for human hepcidin
12/01/2010CN101901656A Preparation method of magnetic particle with surface modified with isothiocyanato active group
12/01/2010CN101900724A Method for identifying cordyceps sinensis phorozoon by using immunohistochemistry
12/01/2010CN101899456A Tonoplast hydrogen pyrophosphatase gene of strong xerophyte zygophyllumxanthoxylum and plant expression vector as well as genetic plant transformation method thereof
12/01/2010CN101899418A Avian influenza virus (AIV) as well as kit and vaccine used for detecting and preventing same
12/01/2010CN101899416A Recombinant rat myeloma cell NS0-F10 and application thereof
12/01/2010CN101899115A Stable CD3-CD19 resisting mini-type difunctional antibody of disulfide bond and preparation method thereof
12/01/2010CN101899114A Antibodies against PD-1 and uses therefor
12/01/2010CN101899113A Humanized antibodies against vascular endothelial growth factor
12/01/2010CN101899112A Light chain and heavy chain variable region of FMU-EPCAM-2D7 monoclonal antibody
12/01/2010CN101899111A Hybridoma cell strain F3
1 ... 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 ... 1494